Feature | January 12, 2012

Experts Offer Pointers for Optimizing Radiation Dose in Pediatric CT

Experts Offer Pointers for Optimizing Radiation Dose in Pediatric CT

January 12, 2012 — An article in the January issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in pediatric computed tomography (CT) scans. Approximately seven to eight million CT examinations are performed for various pediatric clinical indications per year in the United States.

Justification of clinical indication is the most important aspect of reducing radiation dose with CT scanning. A substantial number of pediatric CT scans lack appropriate justification or can be replaced with other imaging modalities with lower or no ionizing radiation, such as radiography, ultrasonography and magnetic resonance imaging (MRI), which can provide similar diagnostic information for some clinical conditions. 

“When not clinically indicated, not performing a CT examination is certainly the best radiation dose reduction strategy. However, when a CT scan is indicated, there are steps that can be taken to optimize the dose that children receive. It’s important that all imaging providers take these steps as indicated,” said Mannudeep K. Kalra, M.D., author of the article. 

Investigators from Massachusetts General Hospital, Harvard Medical School, in Boston, and Johns Hopkins University in Baltimore, reviewed practical strategies for reducing radiation dose associated with pediatric CT examinations. “Radiation dose reduction in children starts with the optimization of pediatric CT protocols,” said Mahadevappa Mahesh, MS, Ph.D., author of the article. “CT protocols should be strictly optimized on the basis of body size, body region, clinical indication and the availability of prior imaging.”

Additional steps include using a lower tube current and voltage, restricting the scan length to include only the region of interest and using new techniques of image post-processing and reconstruction.   

“Children are more sensitive to radiation-induced risks and need special attention. Therefore, while designing CT protocols, it is crucial to keep clinical indications, weight and prior available imaging in mind to optimize radiation dose,” said Mahesh.

 For more information: www.jacr.org, www.imagewisely.org, www.imagegently.org

Related Content

FDA Clears Mirada Medical's Simplicit90y Dosimetry Software
News | Interventional Radiology | February 18, 2019
February 18, 2019 — Mirada Medical Ltd announced U.S.
Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Siemens Healthineers Demonstrates Artificial Intelligence, Healthcare Digitalization at HIMSS19
News | Artificial Intelligence | February 13, 2019
February 13, 2019 — At the 2019 Healthcare Information and Management Systems Society (HIMSS) global conference and e
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Korean National Training Center Installs Carestream OnSight 3D Extremity System
News | Computed Tomography (CT) | February 07, 2019
Jincheon National Training Center in Jincheon, South Korea, installed a Carestream OnSight 3D Extremity System at its...
Canon Medical Debuts Alphenix 4-D CT at RSNA 2018
Technology | Angiography | February 06, 2019
Canon Medical Systems USA Inc. recently introduced a new angiography configuration featuring its Alphenix Sky + C-arm...
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...